Symbol="MREO"
AssetType="Common Stock"
Name="Mereo BioPharma Group PLC ADR"
Description="Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases in the UK and internationally. The company is headquartered in London, the United Kingdom."
CIK="1719714"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, GB"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="157482000"
EBITDA="-43425000"
PERatio="None"
PEGRatio="None"
BookValue="0.496"
DividendPerShare="0"
DividendYield="0"
EPS="-0.36"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.254"
ReturnOnEquityTTM="-0.456"
RevenueTTM="0"
GrossProfitTTM="936000"
DilutedEPSTTM="-0.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="3.97"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.826"
PriceToBookRatio="1.17"
EVToRevenue="0.406"
EVToEBITDA="-2.36"
Beta="0.929"
num_52WeekHigh="1.52"
num_52WeekLow="0.495"
num_50DayMovingAverage="1.239"
num_200DayMovingAverage="0.988"
SharesOutstanding="124986000"
DividendDate="None"
ExDividendDate="None"
symbol="MREO"
open="1.23"
high="1.34"
low="1.19"
price="1.33"
volume="821147.00"
latest_trading_day="2023-07-31"
previous_close="1.26"
change="0.07"
change_percent="5.5556%"
aroon_positive_momentum_days="84"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="84"
Volume_recent_avg="1671490"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="84"
Aroon_momentum_negative="16"
image_negative_thumbnail_id_1="1125"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0158.jpeg"
image_negative_thumbnail_id_2="1105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="675"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_positive_thumbnail_id_2="980"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0142.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
